EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
20.04.23
/
50%
€5.40
Target price
20.04.24
-
Performance (%)
205.00%
End price
21.04.24
€16.47
Summary
This prediction ended on 21.04.24 with a price of €16.47. With a performance of 205.00% the BUY prediction by Robert_W__Baird was a big success. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | 17.274% | 17.274% | 193.280% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten